First Tracks Biotherapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TRAX and other ETFs, options, and stocks.About TRAX
First Tracks Biotherapeutics, Inc. engages in the research and development of immunology therapeutics for autoimmune and inflammatory diseases. It focuses on clinical-stage programs for rosnilimab, ANB033 and ANB101.
TRAX Key Statistics
Stock Snapshot
As of today, First Tracks Biotherapeutics(TRAX) shares are valued at $16.97. The company's market cap stands at 679.34M.
On 2026-05-08, First Tracks Biotherapeutics(TRAX) stock moved within a range of $16.97 to $19.82. With shares now at $16.97, the stock is trading 0.0% above its intraday low and -14.4% below the session's peak.
Trading activity shows a volume of 355.07K, compared to an average daily volume of 536.93K.
The stock's 52-week range extends from a low of $14.79 to a high of $26.80.
The stock's 52-week range extends from a low of $14.79 to a high of $26.80.
Analyst ratings
100%
of 7 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.